BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 43 filers reported holding BIND THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $116,000 | -20.0% | 26,000 | 0.0% | 0.02% | -15.0% |
| Q2 2015 | $145,000 | +1.4% | 26,000 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $143,000 | +66.3% | 26,000 | +62.5% | 0.02% | +53.8% |
| Q4 2014 | $86,000 | -37.2% | 16,000 | 0.0% | 0.01% | -31.6% |
| Q3 2014 | $137,000 | -35.1% | 16,000 | 0.0% | 0.02% | -32.1% |
| Q2 2014 | $211,000 | +36.1% | 16,000 | +23.1% | 0.03% | +33.3% |
| Q1 2014 | $155,000 | -20.9% | 13,000 | 0.0% | 0.02% | -34.4% |
| Q4 2013 | $196,000 | – | 13,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 2,018,253 | $9,001,000 | 6.13% |
| FNY Managed Accounts LLC | 30,000 | $133,800,000 | 0.37% |
| Rhenman & Partners Asset Management AB | 133,535 | $596,000 | 0.10% |
| THOMPSON DAVIS & CO., INC. | 4,500 | $20,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 26,000 | $116,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,593 | $373,000 | 0.01% |
| VANGUARD GROUP INC | 5,488,396 | $177,885,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,786 | $512,000 | 0.01% |
| Renaissance Technologies | 269,300 | $1,201,000 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 324,900 | $1,449,000 | 0.00% |